SCHEMBL8974183

SCHEMBL8974183

NS(=O)(=O)c1ccc(C2=CC(CF)C=C2c2ccc(F)cn2)cc1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.41
CA1 P00915 5/20 0.41
CA9 Q16790 3/20 0.41
CA5A P35218 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
CA4 P22748 1/20 0.41
PTGS2 P35354 12/20 0.41
DRD1 P21728 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
PTGS1 P23219 5/20 0.40
CA12 O43570 2/20 0.37
CA7 P43166 1/20 0.36
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974748 0.93 CA2 (0.41) CA2CA1CA9CA5ACA5B
SCHEMBL8974159 0.89 PTGS2 (0.43) CA2CA1CA9CA5ACA5B
SCHEMBL8974301 0.89 PTGS2 (0.43) CA2CA1CA9CA5ACA5B
SCHEMBL8974752 0.88 PTGS2 (0.44) PTGS2DRD1PTGS1
SCHEMBL8974495 0.86 CA2 (0.44) CA2CA1CA9CA5ACA5B
SCHEMBL8974838 0.86 PTGS2 (0.53) CA2CA1CA9PTGS2DRD1
SCHEMBL8974147 0.85 PTGS2 (0.45) CA2CA1CA9CA5ACA5B
SCHEMBL8974181 0.85 KIF11 (0.48) CA2CA1CA9CA4PTGS2
SCHEMBL8974762 0.84 CA2 (0.42) CA2CA1CA9CA5ACA5B
SCHEMBL8974732 0.83 PTGS2 (0.41) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed